DQB1*0301 is significantly associated with all subgroups of mucous membrane pemphigoid.

DQB1*0301 is significantly associated with all subgroups of mucous membrane pemphigoid.

Bibliographic Details
Main Authors:	Setterfield, J, Shirlaw, P, Vaughan, R, Welsh, K, Wojnarowska, F, Black, M, Challacombe, S
Format:	Journal article
Published:	1997

Similar Items

Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production.
by: Setterfield, J, et al.
Published: (2001)

HLA-DQB1*0301 in Bullous Pemphigoid and Pemphigus Vulgaris: A Meta-Analysis
by: Dylan Thibaut, et al.
Published: (2023-09-01)

BENIGN MUCOUS-MEMBRANE PEMPHIGOID AND PENICILLAMINE
by: Lever, L, et al.
Published: (1985)

Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita.
by: Kirtschig, G, et al.
Published: (2003)

Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
by: Kirtschig, G, et al.
Published: (2002)

Treatment strategies in mucous membrane pemphigoid
by: Ann G Neff, et al.
Published: (2008-06-01)

Mucous membrane pemphigoid in nine children: clinical features, treatment and immunopathology
by: Veysey, E, et al.
Published: (2006)

The efficacy of rituximab in patients with mucous membrane pemphigoid
by: Delara Amir Dastmalchi, et al.
Published: (2022-02-01)

Gut Dysbiosis in Ocular Mucous Membrane Pemphigoid
by: Liying Low, et al.
Published: (2022-04-01)

The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid
by: Mayumi Kamaguchi, et al.
Published: (2019-01-01)

Successful treatment of mucous membrane pemphigoid with bortezomib
by: Lina Saeed, BS, et al.
Published: (2018-01-01)

Tofacitinib for refractory ocular mucous membrane pemphigoid
by: Hayley James, et al.
Published: (2021-06-01)

Mucous membrane pemphigoid: are laminin 5 antibodies a risk factor for laryngeal involvement?
by: Shipman, A, et al.
Published: (2009)

Rapid effector function of circulating NC16A-specific T cells in individuals with mucous membrane pemphigoid.
by: Black, A, et al.
Published: (2004)

Anti-Laminin 332-Type Mucous Membrane Pemphigoid
by: Luhuai Shi, et al.
Published: (2022-10-01)

Mucous membrane pemphigoid - a report of four cases
by: Jocić Ivana, et al.
Published: (2023-01-01)

Role of mini-scleral lens in mucous membrane pemphigoid
by: Mukesh Kumar, et al.
Published: (2017-01-01)

Mucous Membrane Pemphigoid in a Nonagenarian: A Case Report
by: Océane Babin de Lignac, et al.
Published: (2023-09-01)

Desquamative gingivitis as only presenting sign of mucous membrane pemphigoid
by: Veena Vijayan, et al.
Published: (2016-01-01)

Tracheotomy avoided in laryngeal mucous membrane pemphigoid treated with rituximab
by: Daniela A. Brake, et al.
Published: (2020-06-01)

Abstract: HLA-DRB1*16 / HLA-DQB1*0301 Haplotypes Confer Susceptibility to Parry Romberg Syndrome
by: Damian Palafox, MD, et al.
Published: (2018-09-01)

OP-1 Conjunctival genetic ‘fingerprinting’ in ocular mucous membrane pemphigoid
by: Saaeha Rauz, et al.
Published: (2022-05-01)

Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid
by: Roxana Chiorean, et al.
Published: (2018-07-01)

A case of laryngeal mucous membrane pemphigoid possibly triggered by radiotherapy
by: Giovanni M Palleschi, et al.
Published: (2020-01-01)

Severe dapsone-induced hypoalbuminemia in a case of mucous membrane pemphigoid
by: Jasmine Flament, MD, et al.
Published: (2020-10-01)

Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy
by: Anes Yang, et al.
Published: (2018-03-01)

Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment
by: Panagiotis Georgoudis, et al.
Published: (2019-01-01)

The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.
by: Chan, L, et al.
Published: (2002)

Case report: Minimal manifestations of mucous membrane pemphigoid in a young adult
by: Franziska Schauer, et al.
Published: (2022-11-01)

Successful treatment of recalcitrant mucous membrane pemphigoid with multisystem involvement with baricitinib and methotrexate
by: Kevin M. Burningham, MD, et al.
Published: (2022-09-01)

Oral Mucous Membrane Pemphigoid With Positive Nikolsky’s Sign: A Case Report
by: Narjes Akbari, et al.
Published: (2021-01-01)

Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
by: Stephanie Goletz, et al.
Published: (2021-11-01)

The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature
by: Soheil Tavakolpour
Published: (2016-01-01)

Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients
by: Olivier Gaudin, et al.
Published: (2018-05-01)

Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid
by: W. Bernauer, et al.
Published: (2018-08-01)

Direct Immunofluorescence Using Non-Lesional Buccal Mucosa in Mucous Membrane Pemphigoid
by: Mayumi Kamaguchi, et al.
Published: (2018-02-01)

Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature
by: Coralie Zumelzu, et al.
Published: (2018-09-01)

Mucous Membrane Pemphigoid-Associated Malignancies. Case Series and a Brief Overview of the Literature
by: Michelangelo La Placa, et al.
Published: (2019-04-01)

Real-Time Experience of Abrocitinib for the Treatment of Mucous Membrane Pemphigoid: A Case Report
by: Teng Y, et al.
Published: (2024-02-01)

Microbiota Alterations in Patients with Mucous Membrane Pemphigoid and Pemphigus Vulgaris: A Systematic Review
by: Rossella Santoro, et al.
Published: (2023-03-01)